Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
3 of the Fastest-Growing Stocks on the Planet Through 2026
09:51am, Thursday, 07'th Apr 2022 The Motley Fool
These stocks are expected to grow their sales by 26,519% to 100,236% over the next five years.
My Dividend Stock Portfolio: March 2022 Update - 101 Holdings And 29 Buys
05:30am, Thursday, 07'th Apr 2022 Seeking Alpha
The war in Ukraine continues to dominate market movements. Read why I am not selling and predominantly focusing on adding dividend income via select purchases.
Halozyme's (HALO) ENHANZE Drives Sales Amid Rising Competition
12:24pm, Wednesday, 06'th Apr 2022 Zacks Investment Research
Halozyme (HALO) is attracting partnerships from several large pharma companies as well as biotechs, courtesy of its ENHANZE technology. Royalties and product supply to partners are likely to drive rev
2 Biotechs With Recent FDA Approvals to Hold for the Next Decade
11:01am, Wednesday, 06'th Apr 2022 The Motley Fool
With trials aimed at increasing addressable markets in the coming years, Legend and Immunocore could reward investors.
Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know
09:45pm, Monday, 04'th Apr 2022 Zacks Investment Research
Johnson & Johnson (JNJ) closed the most recent trading day at $176.47, moving -0.97% from the previous trading session.
Why the Earnings Surprise Streak Could Continue for Johnson & Johnson (JNJ)
04:10pm, Monday, 04'th Apr 2022 Zacks Investment Research
Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
10 Investor Questions About COVID-19, Answered
02:19pm, Sunday, 03'rd Apr 2022 Benzinga
The COVID-19 outbreak has finally subsided in the U.S., but biotech investors still have plenty of lingering questions about the virus and what to expect in the months and years ahead.
On Thursday, Ba
This Investment Has Been Bringing Home the Bacon for 11 Years -- and Counting
10:10am, Sunday, 03'rd Apr 2022 The Motley Fool
With positive annual returns every year since its inception, this is an all-weather ETF.
2 Drugmakers Set for Explosive Revenue This Decade
10:00am, Sunday, 03'rd Apr 2022 The Motley Fool
They are selling much-needed products.
Here's Why Abbott's a Great Buy Even if COVID Testing Revenue Falls
12:00pm, Saturday, 02'nd Apr 2022 The Motley Fool
This company's other businesses are booming.
Why These 3 Dividend Aristocrats Are Good Buys During a Bear Market
02:39pm, Thursday, 31'st Mar 2022 The Motley Fool
Let dividends reward you even when stock prices are dropping.
My Top Dividend Stock to Buy Now and Hold Forever
02:30pm, Thursday, 31'st Mar 2022 The Motley Fool
This company has a rich history of dividend growth.
The Zacks Analyst Blog Highlights UnitedHealth Group, Johnson & Johnson, Alibaba Group Holding, Oracle and Nike
11:12am, Thursday, 31'st Mar 2022 Zacks Investment Research
UnitedHealth Group, Johnson & Johnson, Alibaba Group Holding, Oracle and Nike have been included in this Analyst Blog.
Top Research Reports for UnitedHealth, Johnson & Johnson, & Alibaba
08:00pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Johnson & Johnson (JNJ), and Alibaba Group Holding Limited (BABA).
